arrow
G

George Fountzilas

George Papanikolaou General Hospital of Thessaloniki
H指数:75
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deciphering site-specific histopathological parameters with potential clinical value in head and neck squamous cell carcinomas

解读头颈鳞状细胞癌中具有潜在临床价值的位点特异性组织病理学参数

2025-12-010
PRE
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.

插入式阿维鲁唑胺联合铂类为基础的化疗在广泛期小细胞肺癌患者中的应用(PAVE):一项多中心Hellenic Cooperative Oncology Group II期研究的最终结果、免疫表型分析和生物标志物分析。

2025-07-250
OAAI
Patient-Reported Outcomes In Patients With Primary Advanced Or Recurrent Endometrial Cancer Treated With Chemotherapy Plus Dostarlimab Or Placebo In The ENGOT-EN6-NSGO/GOG3031/RUBY Trial Over 3 Years Of Follow-Up

ENGOT-EN6-NSGO/GOG3031/RUBY试验中,接受化疗联合Dostarlimab或安慰剂治疗的原发性晚期或复发性子宫内膜癌患者三年随访的结局报告

2025-02-010
PRE
Impact of investigator-assessed response on overall survival (OS) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

研究者评估的反应对原发性晚期或复发性子宫内膜癌(pA/rEC)患者总体生存期(OS)的影响:ENGOT-EN6-NSGO/GOG3031/RUBY试验

2024-09-010
PRE
Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns

癌症中微卫星不稳定性和/或错配修复缺陷的全国真实数据: 患病率和测试模式

2024-05-222
OAAI
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

早期乳腺癌患者采用环磷酰胺与表柔比星序贯、密集给药,随后序贯多西他赛辅助治疗的十年临床疗效、毒性和依从性:一项由希腊肿瘤协作组开展的观察性研究(HE 10/10),并同步探讨肿瘤浸润淋巴细胞的临床意义

BREAST
IF7.9
2024-02-014
OAAI
Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis

晚期非小细胞肺癌患者数字支持的临床和分子研究: snf-climedin,一项前瞻性随机希腊肿瘤协作组 (HeCOG) 研究: 中期分析

2023-10-011
OAAI
COVID-19 in patients with head and neck cancers (HERODOTUS): An international, registry-based, cohort study

头颈癌患者的新型冠状病毒肺炎 (HERODOTUS): 一项基于注册的国际队列研究

2023-10-010
OA
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

曲妥珠单抗时代的剂量密集序贯辅助化疗: 希腊肿瘤协作组HE10/05 III期试验的最终长期结果

2022-05-242
OA
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: Final long-term results of the hellenic cooperative oncology group phase III HE10/05 trial

曲妥珠单抗时代的剂量密集序贯辅助化疗: 希腊肿瘤协作组HE10/05 III期试验的最终长期结果

2022-02-150
PRE
Phased avelumab combined with chemotherapy as first-line treatment in extensive stage small cell lung cancer (PAVE): A phase II Hellenic Cooperative Oncology Group study

分期avelumab联合化疗作为广泛期小细胞肺癌 (PAVE) 的一线治疗: 一项II期希腊合作肿瘤小组研究

2021-09-011
OAAI
Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

接受预防性手术的BRCA1/2携带者的组织基因组学随访

2021-07-240
PREAI
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

来自正常和肿瘤组织的多效性指导的转录组插补确定了乳腺癌和卵巢癌的候选易感基因

2021-07-019
OAAI
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

上皮性卵巢癌患者的肿瘤基因分型和同源重组修复基因变异: 致病性足够吗?

2021-06-011
OAAI
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

头颈癌化疗的荟萃分析 (mach-nc): 代表mach-nc组的107项随机试验和19,805例患者的更新

2021-03-01205
OAAI
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

子宫内膜癌和上皮性卵巢癌的跨癌症全基因组关联研究确定了与两种癌症风险相关的遗传风险区域

2021-01-1115
OAAI
Prevalence and prognostic role of inherited germline mutations in cancer predisposing genes in unselected patients with pancreatic cancer

未经选择的胰腺癌患者中癌症易感基因遗传种系突变的患病率和预后作用

2020-07-010
OAAI
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial

卡巴他赛作为二线治疗先前接受紫杉烷治疗的HER2-negative转移性乳腺癌患者的2期研究-希腊合作肿瘤学组 (HeCOG) 试验

2020-06-0310
OAAI
Actual 5-year survival of dose-dense sequential adjuvant chemotherapy in early breast cancer (BC) patients treated in the post-trastuzumab era: A pooled analysis of 3 clinical trials

后曲妥珠单抗时代早期乳腺癌 (BC) 患者剂量密集序贯辅助化疗的5年实际生存率: 3项临床试验的汇总分析

2020-05-010
OAAI